Successful enteral administration of crushed posaconazole delayed‐release tablets in children

Abstract

AbstractErratic absorption of posaconazole oral suspension necessitates frequent dosing and administration with meals or supplements. Alternative enteral formulations are desirable for patients intolerant to enteral nutrition. Crushed posaconazole delayed‐release tablets (POS‐DRT) show promise in adults; limited evidence exists in children. We used crushed POS‐DRT in 10 encounters with nine pediatric patients, achieving target POS concentrations in 90% of encounters. This highlights crushed POS‐DRT as a potential enteral option for pediatric antifungal prophylaxis and treatment.